4 completed. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
Follow valanafusp alpha: new trials by email Literature Review of valanafusp alpha trials Research Report on valanafusp alpha
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I AGT-181 - Mucopolysaccharidosis I | Phase 1 / Phase 2 | Completed | ArmaGen, Inc | 19 | 2016-10-01 | 2023-03-15 |
| Extension Study of AGT-181-102 to Evaluate Long Term Safety and Activity of AGT-181 AGT-181 - Mucopolysaccharidosis I | Phase 1 | Completed | ArmaGen, Inc | 3 | 2015-11-01 | 2018-09-25 |
| Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I AGT-181 - Mucopolysaccharidosis I | Phase 1 / Phase 2 | Completed | ArmaGen, Inc | 21 | 2015-10-01 | 2023-03-15 |
| Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I AGT-181 (HIRMAb-IDUA) - Mucopolysaccharidosis I | Phase 1 | Completed | ArmaGen, Inc | 3 | 2015-07-01 | 2023-02-21 |
ArmaGen, Inc (4)
Brazil (2) · United States (1)
Patrice P Rioux, MD PhD (2) · Patrice Rioux, MD PhD (2)